{
    "code": "02021841",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021841",
    "time": "2020-02-25 12:47:15",
    "許可證字號": "衛署藥輸字第021841號",
    "註銷狀態": "已註銷",
    "註銷日期": "100\/03\/28",
    "註銷理由": "自請註銷",
    "有效日期": "101\/07\/31",
    "發證日期": "86\/07\/31",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202184104",
    "中文品名": "健擇注射劑",
    "英文品名": "GEMZAR",
    "適應症": "非小細胞肺癌、胰臟癌、膀胱癌、GEMCITABINE與PACLITAXEL併用，可使用於曾經使用過ANTHRACYCLINE之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑藥物(PLATINUM-BASED)治療後復發且間隔至少6個月之卵巢癌，作為第二線治療。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1411301100  臺灣禮來股份有限公司",
        "申請商地址": "台北市復興北路３６５號１１樓",
        "主製造廠": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "1",
            "含量": "1.0000000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "020218410016.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021841&Seq=016&Type=9"
        }
    ]
}